✦ LIBER ✦

Clinical implications of variations in anti-infliximab antibody levels in patients with inflammatory bowel disease

✍ Scribed by Casper Steenholdt; Magid Al-khalaf; Jørn Brynskov; Klaus Bendtzen; Ole Ø. Thomsen; Mark A. Ainsworth

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

962 Clinical Utility of Measuring Inflix

✍ Waqqas Afif; Edward V. Loftus; William A. Faubion; Karen A. Hanson; William J. S 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 47 KB

Impact of measurement of infliximab and

✍ Cardile, S.; Costa, A.; Loddo, I.; Morabito, G.; Pidone, C.; Romano, C. 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 68 KB

Anti-Cardiolipin Antibodies in Patients

✍ Berendt W. Aichbichler; Wolfgang Petritsch; Gerhard A. Reicht; Heimo H. Wenzl; A 📂 Article 📅 1999 🏛 Springer US 🌐 English ⚖ 106 KB

Anti-gal antibodies in patients with inf

✍ D'Alessandro, M.; Mariani, P.; Bachetoni, A.; Lomanto, D.; Mazzocchi, P.; Speran 📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 162 KB

Phosphatidylserine-dependent anti-prothr

✍ Karin Malíčková, Dana Ďuricová, Martin Bortlík, Ivana Janatková… 📂 Article 📅 2012 🏛 Springer-Verlag 🌐 English ⚖ 182 KB

Impact of Antibodies to Infliximab on Cl

✍ Nanda, Kavinderjit S; Cheifetz, Adam S; Moss, Alan C 📂 Article 📅 2013 🏛 Nature Publishing Group 🌐 English ⚖ 286 KB